3 ms·
This was suggested in the US in March and confirmed by Monash University in Australia in April. We ignored it in the US because our medical community is almost
by rpiguy 6y ago
This was suggested in the US in March and confirmed by Monash University in Australia in April.
We ignored it in the US because our medical community is almost completely focused on treating the most severe cases, people who were already vented. I don’t really believe the big pharma conspiracy theory. I do think that in the aftermath a lot of people will question why we didn’t try broad spectrum treatments like ivermectin on patients BEFORE they were severe, even if it only helped a subset it’s a lot cheaper than venting!
- giardini 6y agoVery exciting! The Monash in-vitro study you reference showed shows ivermectin alone cleared viral RNA within 48 hours of a single treatment! https://www.monash.edu/discovery-institute/news-and-events/news/2020-articles/Lab-experiments-show-anti-parasitic-drug,-Ivermectin,-eliminates-SARS-CoV-2-in-cells-in-48-hours https://www.monash.edu/discovery-institute/news-and-events/n... Ivermectin has already been approved for human use against other diseases (as were HCQ and chloroquine). But another problem intrudes: the ivermectin dosage levels required against Covid-19 may be toxic to humans: "The approved dose of ivermectin alone not useful in treating COVID-19": https://www.news-medical.net/news/20200427/Ivermectin-alone-not-useful-in-treating-COVID-19.aspx https://www.news-medical.net/news/20200427/Ivermectin-alone-... But studies will continue: "Human trials begin despite warnings about Monash' COVID-19 head lice study": https://www.smh.com.au/national/human-trials-begin-despite-warnings-about-monash-covid-19-head-lice-study-20200423-p54mm6.html https://www.smh.com.au/national/human-trials-begin-despite-w... Exciting but frustrating work! And meanwhile in Bangladesh they're actually treating people with ivermectin + doxycycline!
- rpiguy 6y agoI agree, but sadly it will likely be ignored here in the US.